Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
1,198
Value
$2.49K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ALLO by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,198$2.49K<0.1%00.0%UnchangedHolders
Q1 20261,198$2.92K<0.1%00.0%UnchangedHolders
Q4 20251,198$1.64K<0.1%−287−19.3%ReducedHolders
Q3 20251,485$1.84K<0.1%+1,485NewHolders
Q2 20250$00.0%−114−100.0%Sold outHolders
Q1 2025114$166<0.1%−107−48.4%ReducedHolders
Q4 2024221$471<0.1%00.0%UnchangedHolders
Q3 2024221$619<0.1%00.0%UnchangedHolders
Q2 2024221$515<0.1%+221NewHolders
Q1 20240$00.0%−32−100.0%Sold outHolders
Q4 202332$103<0.1%−536−94.4%ReducedHolders
Q3 2023568$1.80K<0.1%+230+68.0%AddedHolders
Q2 2023338$1.68K<0.1%+40+13.4%AddedHolders
Q1 2023298$1.47K<0.1%00.0%UnchangedHolders
Q4 2022298$1.87K<0.1%+174+140.3%AddedHolders
Q3 2022124$1.00K<0.1%−464−78.9%ReducedHolders
Q2 2022588$7.00K<0.1%−286−32.7%ReducedHolders
Q1 2022874$8.00K<0.1%−402−31.5%ReducedHolders
Q4 20211,276$19.0K<0.1%00.0%UnchangedHolders
Q3 20211,276$33.0K<0.1%−389−23.4%ReducedHolders
Q2 20211,665$43.0K<0.1%+400+31.6%AddedHolders
Q1 20211,265$45.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.